PRESS RELEASE published on 01/18/2024 at 13:00, 2 years 8 months ago Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
PRESS RELEASE published on 01/16/2024 at 13:00, 2 years 8 months ago Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
PRESS RELEASE published on 11/15/2023 at 13:00, 2 years 10 months ago Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
PRESS RELEASE published on 06/15/2023 at 13:00, 3 years 3 months ago OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
PRESS RELEASE published on 05/09/2023 at 13:00, 3 years 5 months ago Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
PRESS RELEASE published on 05/04/2023 at 13:00, 3 years 5 months ago Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
PRESS RELEASE published on 05/03/2023 at 15:05, 3 years 5 months ago Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
PRESS RELEASE published on 05/01/2023 at 13:00, 3 years 5 months ago Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
PRESS RELEASE published on 03/30/2023 at 13:00, 3 years 6 months ago Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
PRESS RELEASE published on 03/29/2023 at 17:45, 3 years 6 months ago Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Published on 10/13/2026 at 15:00, 18 minutes ago Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Published on 10/13/2026 at 14:45, 33 minutes ago Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
Published on 10/13/2026 at 14:31, 47 minutes ago First Breach Completes First Autonomous Flight of Proprietary Drone Prototype
Published on 10/13/2026 at 14:10, 1 hour 8 minutes ago NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 14:00, 1 hour 18 minutes ago Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold
Published on 10/13/2026 at 15:05, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/13/2026 at 15:05, 12 minutes ago Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats
Published on 10/13/2026 at 15:03, 14 minutes ago Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 10/13/2026 at 09:04, 6 hours 13 minutes ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 21 hours 18 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 23 hours 30 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026